December 11-13, 2023
DoubleTree By Hilton | Philadelphia, PA
Exclusive Offer–Be sure to use your exclusive promo code 23DC10 to save 10% off* of your registration.
Trade and Channel Strategies is back and we have a lot to talk about! With regulation and policy changes, specifically surrounding the DCSCA, IRA and serialization, the loss of exclusivity wave, adoption of low-WAC products affecting GTN and the rise of alternative distribution models, there has never been a more important time for industry to unite. A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023.
Exclusive Offer–Download the agenda and register today–Be sure to use your exclusive promo code 23DC10 to save 10% off* of your registration.
Why should you attend this pivotal event?
The challenges of keeping up with shifting market dynamics in the midst of maximizing market access while also meeting business objectives remains a deep concern and brings about many questions for trade and channel professionals.
Have you properly prepared for the DSCSA to take effect and what should you expect post implementation? How is health policy affecting the distribution channel? How are product archetypes and market expansion influencing the physical channel and what does that mean for your organization?
In just three days, walk away with answers to these questions and more from experts from across the industry. Do not miss your chance to join seasoned leaders, your peers and leading solution providers as they dive into the top trends for innovative distribution, integrated pharmacy models and the future of trade.
What can you expect?
Vital insights from some of the industry’s leading pharmacy and distribution experts, including:
- Bill Roth, General Manager and Managing Partner, Blue Fin Group, An IntegriChain Company
- Jeff Henderson, Vice President, Head of Global Market Access, Reimbursement and Distribution, VectivBio
- David T. Foell, Director, Specialty Channel Operations, Ultragenyx
- Chris Rocco, Senior Director, Market Access Data, Reporting and Analytics, GSK
- Spencer Miller, Director, Market Access, National Accounts, Trade & Distribution, Bayer
- Dana Dickens, Senior Director, Trade, Gilead Sciences
- Rena Goins, Executive Director, Global Distribution, Regeneron Pharmaceuticals, Inc.
- Eduardo De La Calle, Director of Regional Supply, AstraZeneca
- Shefali Shah, Global VP, Market Value and Commercial Effectiveness, MindMaze
- And more!
- Keynote: The State of the Channel — Overview of Current and Future Trends Impacting the Channel
- Wall Street Insights — Analyze Market Dynamics and Key Investments in the Healthcare Ecosystem
- Focused Multi-Track Offerings:
- Supply Chain and Distribution Operations
- Pharmacy Model Strategies and Management
- Data, Innovation and Analytics
- Supply in Crisis—How Can We Better Prepare
- How to Maximize GTN Impact for Channel Strategy
- Diversity, Equity and Inclusion Summit
- Interactive Working Groups Based on Product Type:
- Branded Products
- Specialty, Orphan and Rare
- Generics and Biosimilars
- The Flavors of Retail Pharmacy—Exploring Various Models in the Marketplace
- The State of the IRA and Navigating What Comes Next
- Thought-Provoking Workshops by Role Type:
- Trade 101 for Existing Products
- Portfolio Management and Launch Strategy
- Executive Trade Directors Exchange
- Distribution for Digital Therapeutics
- And more!
Exclusive Offer–Download the agenda and register today–Be sure to use your exclusive promo code 23DC10 to save 10% off* of your registration.
Informa Connect will see you there!
*Cannot be combined with other offers, promotions or applied to an existing registration. Other restrictions may apply.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net).
No comments:
Post a Comment